Female Androgenetic Alopecia clinical trials

Explore recruiting female androgenetic alopecia clinical trials.

Recruiting female androgenetic alopecia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Female Androgenetic Alopecia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

International Phase III, Multi-center, Randomized, Double-blind, Placebo and Active-controlled and Parallel group Clinical Trial to Evaluate the Efficacy and Safety of Oral Minoxidil 1 mg in Female patients with Androgenetic Alopecia.

Portugal, Spain, Germany, Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Female Androgenetic Alopecia trials by city

Female Androgenetic Alopecia in Toronto Female Androgenetic Alopecia in Vancouver Female Androgenetic Alopecia in Montreal Female Androgenetic Alopecia in Calgary Female Androgenetic Alopecia in Edmonton Female Androgenetic Alopecia in Ottawa Female Androgenetic Alopecia in Winnipeg Female Androgenetic Alopecia in Quebec City Female Androgenetic Alopecia in Hamilton Female Androgenetic Alopecia in Kitchener Female Androgenetic Alopecia in London Female Androgenetic Alopecia in Halifax Female Androgenetic Alopecia in New York Female Androgenetic Alopecia in Los Angeles Female Androgenetic Alopecia in Chicago Female Androgenetic Alopecia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease